Stay updated with breaking news from Kyle Yang. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Oppenheimer initiated coverage on Fusion Pharmaceuticals Inc (NASDAQ: FUSN), citing the company's pipeline as among the best in the space with alpha-emitter-based targeted radionuclide therapies (TRTs), with three currently in clinical development.
Oppenheimer initiated coverage on Fusion Pharmaceuticals Inc FUSN, citing the company's pipeline as among the best in the space with alpha-emitter-based…
Oppenheimer has initiated coverage on Corvus Pharmaceuticals Inc (NASDAQ: CRVS) with an Outperform rating and a
/PRNewswire/ -- Following the success of its Ranger e-Bike launch last year, Heybike® has unveiled its upgraded, most advanced e-Bike model yet, the Ranger S....
/PRNewswire/ -- Oracle today announced that MySQL HeatWave is available on Amazon Web Services (AWS). MySQL HeatWave is the only service that combines OLTP,...